Venetoclax Synergizes with Radiotherapy for Treatment of B-cell Lymphomas

Constitutive B-cell receptor signaling leads to overexpression of the anti-apoptotic BCL-2 protein and is implicated in the pathogenesis of many types of B-cell Non-Hodgkin Lymphoma (B-NHL). The BCL-2 small molecule inhibitor venetoclax shows promising clinical response rates in several lymphomas, b...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Cancer Res
Autors principals: O’Steen, Shyril, Green, Damian J., Gopal, Ajay K., Orozco, Johnnie J., Kenoyer, Aimee L., Lin, Yukang, Wilbur, D. Scott, Hamlin, Donald K., Fisher, Darrell R., Hylarides, Mark D., Gooley, Theodore A., Waltman, Amelia, Till, Brian G., Press, Oliver W.
Format: Artigo
Idioma:Inglês
Publicat: 2017
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5560265/
https://ncbi.nlm.nih.gov/pubmed/28566329
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/0008-5472.CAN-17-0082
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars